文献速递角膜与眼表疾病

我们能根除沙眼吗?利益相关者调查

Can we eradicate trachoma? A survey of stakeholders.
PubMed 文献 · Br J Ophthalmol · 2020-08-27

BACKGROUND/AIMS: Although tremendous progress towards the 2020 goal of global elimination of trachoma as a public health problem has been made, it will not be achieved. Future targets are now being considered. One option is changing the goal to eradication.…

要点

  • 91%受访专家认为阿奇霉素群体给药最重要目标是控制或消除感染,而非根除。
  • 24%受访者认为全球根除沙眼不可能,给出年份者多集中在2040至2050年。
  • 主要障碍为缺乏确认根除或监测感染复燃的监测工具(32%)及资源不足(23%)。

核心结论

  • 多数受访沙眼专家将阿奇霉素群体给药的首要目标视为控制或消除感染,而非根除。
  • 约四分之一受访者认为全球根除沙眼不可能,认为可实现者多预期在2040至2050年。

主要发现

  • 91%受访者报告阿奇霉素群体给药最重要目标是控制或消除感染。
  • 24%受访者报告全球根除不可能。
  • 76%受访者给出可根除年份,其中多数集中在2040至2050年。
  • 常见障碍包括缺乏确认根除或监测感染复燃的监测工具(32%)和资源不足(23%)。

临床怎么用

  • 开发替代性沙眼监测指标并持续投入沙眼项目、重点支持高负担人群,可能提升对根除可行性的信心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Although tremendous progress towards the 2020 goal of global elimination of trachoma as a public health problem has been made, it will not be achieved. Future targets are now being considered. One option is changing the goal to eradication. We surveyed trachoma experts to assess beliefs related to trachoma eradication and determine perceived obstacles to achieving it. METHODS: We conducted a survey at the beginning of a trachoma eradication session at the 2019 Coalition for Operational Research on Neglected Tropical Diseases meeting in National Harbor, Maryland, USA. We asked respondents what the most important goal of azithromycin mass drug administration was for trachoma (control, elimination of infection or eradication) and if and when they believed trachoma eradication would occur. We then asked what the biggest obstacles were to global eradication. RESULTS: Fifty-six surveys were returned (95%). Most (91%) participants reported that the most important goal of azithromycin mass drug administration was control or elimination of infection, and 24% of participants reported that global eradication was not possible. Of the 76% who reported a year by which they believed trachoma could be eradicated, most fell between 2040 and 2050. Commonly cited barriers to global eradication included lack of surveillance tools to confirm eradication or monitor for infection recrudescence (32%) and lack of resources (23%). CONCLUSIONS: Development of alternative indicators for trachoma surveillance and continued investment in trachoma programmes, particularly focused support in the most heavily affected populations, might increase enthusiasm for the feasibility of eradication.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Oldenburg CE, Aragie S, Amza A, et al. Can we eradicate trachoma? A survey of stakeholders. Br J Ophthalmol. 2020. PMID: 32855161. doi:10.1136/bjophthalmol-2020-315815

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。